| 1 |
35240967 | Deciphering the significance of plasma chemokines as prognostic biomarkers in Pegylated IFN-α-2a /ribavirin-treated chronic hepatitis C genotype 4 patients. | 2022 Mar 3 |
2 |
| 2 |
31383827 | The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study. | 2019 Apr |
1 |
| 3 |
30245117 | Two novel SNPs in the promoter region of PKR gene in hepatitis C patients and their impact on disease outcome and response to treatment. | 2018 Sep |
1 |
| 4 |
23399035 | The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells. | 2013 Mar 30 |
2 |
| 5 |
23553458 | Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin. | 2013 Sep |
2 |
| 6 |
24009705 | Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation. | 2013 |
2 |
| 7 |
21145800 | IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy. | 2011 Jun |
1 |
| 8 |
17501760 | Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin. | 2007 Jun |
1 |
| 9 |
17597457 | Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus. | 2007 Aug 1 |
6 |
| 10 |
15535414 | PKR gene expression and response to pegylated interferon plus ribavirin therapy in chronic hepatitis C. | 2004 Oct |
2 |